Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 11, pseudogene (RN7SL11P) is a pseudogene corresponding to the 7SL RNA family. The 7SL RNA is an essential non-coding RNA component of the signal recognition particle (SRP) complex, which directs protein targeting to the endoplasmic reticulum, but pseudogenes like RN7SL11P are non-functional copies dispersed throughout the genome[2][5]. 7SL pseudogenes arise from reverse transcription-derived integration of 7SL RNA sequences but do not produce functional RNA or protein. While functional 7SL RNA plays roles in ribonucleoprotein assembly, translation regulation, and possibly in cancer cell communication, this specific pseudogene does not encode an active, therapeutic, or disease-relevant target[2][5]. There is no evidence RN7SL11P is involved in any direct biological functions, disease mechanisms, or is a drug target. Clarification: This entry is a pseudogene, not a functional target. It is not considered a therapeutic target, enzyme, receptor, transporter, or similar entity[2][5]. If you are seeking information about the functional 7SL RNA or the signal recognition particle RNA, refer to those entities rather than to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 11, pseudogene (RN7SL11P).